Rheumatology

Latest News

Group of doctors talking and looking at tablet | Image credit: Seventyfour – stock.adobe.com
Patients With RA and Cancer Seek More Clarity, Collaboration in Treatment Decisions

July 9th 2025

Many patients value conversations with their rheumatologists and oncologists more than just reading information from a website.

Older woman eating salad on yoga mat | Image credit: Prostock-studio – stock.adobe.com
Plant-Based Diet May Improve Stress-Related Metrics in Rheumatoid Arthritis

July 3rd 2025

Dentist consulting patient | Image credit: D Theron/peopleimages.com – stock.adobe.com
Dental Infections Pose Risks for Hospitalized Patients With Rheumatoid Arthritis

June 30th 2025

Doctor explaining notes to patient | Image credit: Minerva Studio – stock.adobe.com
Patient Materials for Rheumatoid Arthritis Often Miss Crucial Information

June 30th 2025

Stressed older woman | Image credit: InsideCreativeHouse – stock.adobe.com
Musculoskeletal Disorders in Postmenopausal Women Are Rising Worldwide

June 24th 2025

More News

doctor writing on form
July 29th 2022

Study Highlights 6 Aspects of Daily Life Affected by RA

Hayden E. Klein
Interviews conducted with patients with rheumatoid arthritis (RA) revealed 6 important aspects of daily life that are rarely measured in RA research.
person holding white pills and glass of water
July 26th 2022

Early Methotrexate Did Not Prevent Arthritis Development, Study Found

Hayden E. Klein
While a 1-year course of methotrexate improved physical function, pain, morning joint stiffness, and joint inflammation, it did not prevent the development of clinical arthritis.
telemedicine appointment
July 23rd 2022

Patients Who Have Rheumatic Disease May Benefit From Telemedicine

Lindsey Mulrooney
A systemic review found that patients with rheumatic diseases experienced comparable outcomes and satisfaction from telemedicine compared with in-person treatment.
woman with fever looking at thermometer
July 21st 2022

Rheumatic Conditions Are a Common Cause of Unexplained Fever, Inflammation

Hayden E. Klein
A review found rheumatic conditions cause 22.2% of global cases of fever and inflammation of unknown origin.
patient consulting with doctor
July 12th 2022

AYAs Emphasize Importance of Patient Perspectives During Health Care Transition

Hayden E. Klein
None of the adolescent and young adult (AYA) participants in a study reported experiencing the Six Core Elements of Healthcare Transition during their rheumatology health care transition.
Image of telehealth appointment
July 10th 2022

Telerehabilitation Reduces Pain, Improves Function for People With Musculoskeletal Needs

Lindsey Mulrooney
Participants in a digital acute musculoskeletal (MSK) program experienced better pain and function outcomes vs nonparticipants, demonstrating benefits for acute and subacute MSK conditions.
FDA Approved
July 8th 2022

FDA Approves Pegloticase Injection Coadministered With Methotrexate for Gout

Hayden E. Klein
Pegloticase (Krystexxa) injection coadministered with methotrexate received FDA approval for the treatment of gout.
white pills falling out of pill bottle
July 1st 2022

Safety Trends Following DMARD Treatment in Patients With RA

Hayden E. Klein
Researchers found that risk of adverse events and mortality did not increase following certain rheumatoid arthritis (RA) treatments.
Overweight female out for walk with friend
June 30th 2022

Treatment Outcomes for Patients With AS, PsA May Be Impacted by Time to Diagnosis, Gender, BMI

Lindsey Mulrooney
Outcomes for patients with ankylosing spondylitis (AS) and psoriatic arthritis (PsA) may depend on gender, time to diagnosis, and body mass index (BMI), according to subanalyses of the AQUILA study of patients taking secukinumab.
Charts showing data
June 23rd 2022

Abstracts Highlight Racial Disparities in Gout Prevalence, ED Visits, and Hospitalizations

Lindsey Mulrooney
Abstracts presented at EULAR 2022 focused on racial differences in gout prevalence and treatment, highlighting racial disparities in recent decades.
healthy foods on table
June 20th 2022

Evidence of Dietary Benefits on RMD Outcomes Is Limited, Review Says

Hayden E. Klein
Based on limited existing evidence, a systematic review found no single dietary factor had a meaningful impact on rheumatic and musculoskeletal disease (RMD) outcomes.
couple walking
June 17th 2022

Walking for Exercise Can Benefit Older Adults With Osteoarthritis, Study Says

Hayden E. Klein
Adults aged 50 and older who walked for exercise were less likely to develop new frequent knee pain and medial joint space narrowing.
pregnant woman in hospital bed
June 14th 2022

Study Finds 2 Factors Associated With Adverse Outcomes Among Pregnant Women With RA

Hayden E. Klein
Prior miscarriage and antinuclear antibody positivity are independent risk factors associated with adverse pregnancy outcomes among women with rheumatoid arthritis (RA).
two doctors talking to patient
June 11th 2022

Mental Models Highlight Discrepancies Between Rheumatologists, Patients During TTT Therapy

Hayden E. Klein
The developers of these models said the next step is to determine how to incorporate these patient perspectives into clinical rheumatology practice.
gender symbols on balanced scale
June 10th 2022

Abstracts Highlight Sex-Based Differences in IA Management

Hayden E. Klein
Abstracts presented at EULAR 2022 focused on sex-related differences in inflammatory arthritis (IA) management, including adherence to electronically reporting outcomes and disparities in health care utilization.
doctor talking to patient
June 3rd 2022

Disease Characteristics of UCTD Differ From CTD, HSS Researchers Find

AJMC Staff
Undifferentiated connective tissue disease (UCTD) is challenging to define but is a distinct clinical entity from connective tissue diseases (CTD).
woman exercising in pool
June 1st 2022

Researchers Evaluate Whether Aquatic Exercise Is Most Effective Therapy for IA

Hayden E. Klein
Research supports that aquatic exercise is effective at reducing pain and disease activity and improving physical function, although it is unclear whether it is more effective than any other form of therapy for inflammatory arthritis (IA).
cutting health care costs
May 26th 2022

ACR Calls for Drug Pricing Reforms, Urges FTC to Address PBM Practices

Hayden E. Klein
A letter from the American College of Rheumatology (ACR) called for drug pricing reforms, deeming them necessary to ensure the health of patients and sustainability of health care systems.
Secukinumab Improved HRQOL, Symptoms in Pediatric Generalized Pustular Psoriasis
May 20th 2022

Secukinumab Improved HRQOL, Symptoms in Pediatric Generalized Pustular Psoriasis

Allison Inserro
Over 48 weeks, secukinumab was shown to be effective and safe in a small study of 18 children with generalized pustular psoriasis in China.
medical marijuana
May 17th 2022

Researchers Suggest Cons of Cannabinoids in Rheumatology Outweigh Pros

Hayden E. Klein
While current data on medical cannabinoids in rheumatology is limited, findings suggest that adverse events (AEs) and drug interactions outweigh the benefits.
medical technology
May 13th 2022

Machine Learning–Based Predictors for RA Relapse Evaluated

Hayden E. Klein
Researchers found that the extreme gradient boosting (XGBoost) predictor could more accurately predict rheumatoid arthritis (RA) relapse than logistic regression and random forest.
male doctor with female patient
May 10th 2022

Age, Sex, Socioeconomic Status Play a Role in Likelihood of Consistent RA Treatment, Study Says

Hayden E. Klein
Male sex, older age, lower socioeconomic status, higher comorbidity score, and having an older or male rheumatologist were associated with the reduced likelihood of continuing with rheumatoid arthritis (RA) treatment.
blood samples
May 6th 2022

Men With ACPA-Negative Early RA More Likely to Achieve Remission Than Women, Study Suggests

Hayden E. Klein
According to the authors, sex-based differences may be a cause of higher rheumatoid arthritis (RA) disease activity.
doctor and nurse with patient
May 3rd 2022

Patient-Physician Discordance Associated With Lack of RA Clinical Remission

Hayden E. Klein
Among patients with rheumatoid arthritis (RA) in clinical remission, patient-physician discordance when assessing disease activity may be associated with the inability to achieve remission.
doctor filling out paperwork
April 26th 2022

High Prevalence of Metabolic Syndrome in Patients With RA Warrants Early Identification Measures

Hayden E. Klein
A meta-analysis found that a third of patients with rheumatoid arthritis (RA) in a sample had metabolic syndrome, which can double the risk of cardiovascular outcomes in this population.
hand with arthritis
April 23rd 2022

Secukinumab 300 mg Dose Improved Symptoms of Psoriatic Arthritis, Study Finds

Hayden E. Klein
Results from the CHOICE study suggest that both a 150 mg and 300 mg dose of secukinumab improved symptoms of psoriatic arthritis (PsA) in biologic-naïve patients, with higher response rates for the 300 mg dose.
eye graphic
April 19th 2022

Early Immunosuppressive Therapy Linked to Better Outcomes for RA-Associated Peripheral Ulcerative Keratitis

Hayden E. Klein
Patients who received early immunosuppressive therapy for their rheumatoid arthritis (RA)–associated peripheral ulcerative keratitis experienced earlier inflammatory control, fewer recurrences, and better visual outcomes.
doctor paperwork
April 16th 2022

Study Finds Time-Varying Association Between RA Disease Activity and CVD Risk

Hayden E. Klein
The association between higher disease activity risk of cardiovascular (CV) events was strongest during the first 6 months of follow-up, the study found.
pills and syringe
April 12th 2022

Study Finds No Association Between Targeted DMARDs, ADRD Risk Among Patients With RA

Hayden E. Klein
Researchers found no association between the use of tofacitinib, tocilizumab, or tumor necrosis factor (TNF) inhibitors and risk of developing Alzheimer disease and related dementia (ADRD) among older patients with rheumatoid arthritis (RA).
parent, child, and pediatrician
April 6th 2022

Study Finds Delays in Initial Pediatric Rheumatologist Visit for Older Children With JIA

Hayden E. Klein
Age at symptom presentation was significantly associated with longer symptom duration for children with juvenile idiopathic arthritis (JIA).
<12345678
...
11>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo